Supported Assets
Soon Open Mo
Syndax Pharmaceuticals
$8.72
-over selected period
$0.00 (0.00%)since US close
- Onchain price
- $8.72
- Last close
- $8.72Yahoo Finance ยท
- Premium / discount
- -
Price differences before fees and execution costs. Compare prices
About Syndax Pharmaceuticals
A commercial-stage biopharmaceutical company advancing cancer therapies, including its approved medicines Revuforj (revumenib) and Niktimvo (axatilimab-csfr), alongside clinical development programs.
Token
- Token
- SNDXc
- Shares per token
- 1.00000000 SNDX
